The cardiovascular-immune axis: crosstalk and therapy in atherosclerosis, myocarditis and vasculitis. [PDF]
Liao YP +6 more
europepmc +1 more source
Myocarditis Following Invasive Group A <i>Streptococcus</i> Infection: Important Differential Diagnostic Distinctions. [PDF]
Oxman JM, Bourne M, Perlman DC, Sells N.
europepmc +1 more source
Recovery from fulminant immune-related myocarditis induced by ipilimumab plus nivolumab in malignant pleural mesothelioma: a case report. [PDF]
Konya Y +8 more
europepmc +1 more source
Screening for cardiac conditions associated with sudden cardiac death in the young : external review against programme appraisal criteria for the UK National Screening Committee [PDF]
Bradlow, William +8 more
core
Case Report and literature review: immune checkpoint inhibitor-associated myasthenia gravis and myocarditis. [PDF]
Shang Z, Hao S, Wang J, Li W.
europepmc +1 more source
Efgartigimod as Rescue Therapy for PD-1 Inhibitor-Associated Myasthenia Gravis, Myocarditis, and Myositis (MMM) Syndrome: A 2-Case Report and Literature Review. [PDF]
Liu ZH +7 more
europepmc +1 more source
Hyperbaric Oxygen Therapy in Experimental Autoimmune Myocarditis: Insights from Preclinical Models to Translational Perspectives. [PDF]
Pindovic B +11 more
europepmc +1 more source
Highly suspected fulminant myocarditis induced by the immune checkpoint inhibitor tislelizumab: a case report with third-degree atrioventricular block and recurrent ventricular tachycardia. [PDF]
Qu J +7 more
europepmc +1 more source
Fulminant Influenza B Myocarditis in an Adolescent Requiring Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO): Complete Recovery at a Pediatric Cardiac Referral Center in Mexico. [PDF]
Gilles-Herrera C +8 more
europepmc +1 more source
Immune Checkpoint Inhibitor-Associated Myocarditis With Multisystem Immune Toxicity in Renal Cell Carcinoma. [PDF]
Chennuri RN +7 more
europepmc +1 more source

